Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.
Saved in:
| Title: | Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine. |
|---|---|
| Authors: | Kofoed SV; Evaxion Biotech, Hørsholm, Denmark. svk@evaxion.ai., Barrio-Calvo M; Evaxion Biotech, Hørsholm, Denmark., Pavlidis MA; Evaxion Biotech, Hørsholm, Denmark., Kleine-Kohlbrecher D; Evaxion Biotech, Hørsholm, Denmark., Lausen M; Evaxion Biotech, Hørsholm, Denmark., Lunabjerg-Vestergaard C; Evaxion Biotech, Hørsholm, Denmark., Viborg N; Evaxion Biotech, Hørsholm, Denmark., Garde C; Evaxion Biotech, Hørsholm, Denmark., Rønø B; Evaxion Biotech, Hørsholm, Denmark., Friis S; Evaxion Biotech, Hørsholm, Denmark. sf@evaxion.ai. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Jul 24; Vol. 74 (9), pp. 276. Date of Electronic Publication: 2025 Jul 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40705109 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kofoed+SV%22">Kofoed SV</searchLink>; Evaxion Biotech, Hørsholm, Denmark. svk@evaxion.ai.<br /><searchLink fieldCode="AU" term="%22Barrio-Calvo+M%22">Barrio-Calvo M</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Pavlidis+MA%22">Pavlidis MA</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Kleine-Kohlbrecher+D%22">Kleine-Kohlbrecher D</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Lausen+M%22">Lausen M</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Lunabjerg-Vestergaard+C%22">Lunabjerg-Vestergaard C</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Viborg+N%22">Viborg N</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Garde+C%22">Garde C</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Rønø+B%22">Rønø B</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Friis+S%22">Friis S</searchLink>; Evaxion Biotech, Hørsholm, Denmark. sf@evaxion.ai. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 Jul 24; Vol. 74 (9), pp. 276. <i>Date of Electronic Publication: </i>2025 Jul 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40705109 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-025-04120-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 276 Titles: – TitleFull: Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kofoed SV – PersonEntity: Name: NameFull: Barrio-Calvo M – PersonEntity: Name: NameFull: Pavlidis MA – PersonEntity: Name: NameFull: Kleine-Kohlbrecher D – PersonEntity: Name: NameFull: Lausen M – PersonEntity: Name: NameFull: Lunabjerg-Vestergaard C – PersonEntity: Name: NameFull: Viborg N – PersonEntity: Name: NameFull: Garde C – PersonEntity: Name: NameFull: Rønø B – PersonEntity: Name: NameFull: Friis S IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 07 Text: 2025 Jul 24 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 74 – Type: issue Value: 9 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |